|
ATE429927T1
(en)
|
2000-02-04 |
2009-05-15 |
Children S Hospital Res Founda |
USE OF LYSOSOMAL ACID LIPASE TO TREAT ATHEROSCLERosis AND SIMILAR DISEASES
|
|
EP2370577B1
(en)
|
2008-12-03 |
2019-08-28 |
Arcturus Therapeutics, Inc. |
Usirna complexes
|
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
|
KR101742346B1
(en)
|
2010-04-23 |
2017-06-15 |
시나게바 바이오파르마, 코포레이션 |
Lysosomal storage disease enzyme
|
|
CN105457018A
(en)
|
2010-09-09 |
2016-04-06 |
辛那杰瓦生物制药股份有限公司 |
Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
|
|
KR20140006037A
(en)
|
2011-02-15 |
2014-01-15 |
시나게바 바이오파르마, 코포레이션 |
Methods for treating lysosomal acid lipase deficiency
|
|
US20140378533A1
(en)
|
2012-02-08 |
2014-12-25 |
Isis Pharmaceuticals, Inc. |
Modulation of rna by repeat targeting
|
|
AU2013226081B2
(en)
|
2012-02-27 |
2018-06-14 |
Becton, Dickinson And Company |
Compositions and kits for molecular counting
|
|
EP2831232A4
(en)
|
2012-03-30 |
2015-11-04 |
Univ Washington |
METHOD FOR MODULATING TAU EXPRESSION TO REDUCE PROBLEMS AND MODIFY A NEURODEGENERATIVE SYNDROME
|
|
RU2745324C2
(en)
|
2013-03-14 |
2021-03-23 |
Ионис Фармасьютикалз, Инк. |
Compositions and methods for modulating expression of tau
|
|
ES2649490T3
(en)
|
2013-03-14 |
2018-01-12 |
Alnylam Pharmaceuticals, Inc. |
Compositions of RNAi against component C5 of the complement and methods for its use
|
|
KR102712053B1
(en)
|
2013-05-01 |
2024-10-02 |
아이오니스 파마수티컬즈, 인코포레이티드 |
Compositions and methods for modulating hbv and ttr expression
|
|
TWI657819B
(en)
|
2013-07-19 |
2019-05-01 |
美商Ionis製藥公司 |
Composition for regulating the expression of tau protein
|
|
SG10201806890VA
(en)
|
2013-08-28 |
2018-09-27 |
Cellular Res Inc |
Massively parallel single cell analysis
|
|
PL3119888T3
(en)
*
|
2014-03-19 |
2021-12-20 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating ataxin 2 expression
|
|
BR112016022711A2
(en)
*
|
2014-04-01 |
2017-10-31 |
Monsanto Technology Llc |
compositions and methods for insect pest control
|
|
RU2739987C2
(en)
|
2014-05-23 |
2020-12-30 |
Джензим Корпорейшн |
Multiple oligonucleotide fragments on a peptide carrier
|
|
CA2960728C
(en)
*
|
2014-09-18 |
2023-06-06 |
The University Of British Columbia |
Allele-specific therapy for huntington disease haplotypes
|
|
CA2976445A1
(en)
*
|
2015-02-13 |
2016-08-18 |
Alnylam Pharmaceuticals, Inc. |
Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
|
|
ES2934982T3
(en)
|
2015-03-30 |
2023-02-28 |
Becton Dickinson Co |
Methods for encoding with combinatorial barcodes
|
|
US10619186B2
(en)
|
2015-09-11 |
2020-04-14 |
Cellular Research, Inc. |
Methods and compositions for library normalization
|
|
WO2017100542A1
(en)
|
2015-12-10 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof
|
|
WO2017117496A1
(en)
|
2015-12-31 |
2017-07-06 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing ataxin-2 expression
|
|
CA3013797A1
(en)
|
2016-03-09 |
2017-09-14 |
Ionis Pharmaceuticals, Inc. |
Methods and compositions for inhibiting pmp22 expression
|
|
US10301677B2
(en)
|
2016-05-25 |
2019-05-28 |
Cellular Research, Inc. |
Normalization of nucleic acid libraries
|
|
US10640763B2
(en)
|
2016-05-31 |
2020-05-05 |
Cellular Research, Inc. |
Molecular indexing of internal sequences
|
|
US10202641B2
(en)
|
2016-05-31 |
2019-02-12 |
Cellular Research, Inc. |
Error correction in amplification of samples
|
|
UY37376A
(en)
*
|
2016-08-26 |
2018-03-23 |
Amgen Inc |
ARNI CONSTRUCTIONS TO INHIBIT EXPRESSION OF ASGR1 AND METHODS FOR USE
|
|
KR102363716B1
(en)
|
2016-09-26 |
2022-02-18 |
셀룰러 리서치, 인크. |
Determination of protein expression using reagents having barcoded oligonucleotide sequences
|
|
JOP20190065A1
(en)
|
2016-09-29 |
2019-03-28 |
Ionis Pharmaceuticals Inc |
Compounds and Methods for Reducing the Expression of TAU
|
|
EP3533868A4
(en)
*
|
2016-10-31 |
2019-12-11 |
Gifu University |
DOUBLE-STRANDED NUCLEIC ACID MOLECULE AND USE THEREOF
|
|
US11319583B2
(en)
|
2017-02-01 |
2022-05-03 |
Becton, Dickinson And Company |
Selective amplification using blocking oligonucleotides
|
|
CA3051839A1
(en)
|
2017-02-17 |
2018-08-23 |
Bristol-Myers Squibb Company |
Antibodies to alpha-synuclein and uses thereof
|
|
JOP20190215A1
(en)
*
|
2017-03-24 |
2019-09-19 |
Ionis Pharmaceuticals Inc |
Modulators of pcsk9 expression
|
|
NO344051B1
(en)
*
|
2017-05-04 |
2019-08-26 |
Patogen As |
Novel virus in Fish and Method for detection
|
|
US11643656B2
(en)
|
2017-05-24 |
2023-05-09 |
The Regents Of The University Of California |
Antisense therapies for treating cancer
|
|
CA3059559A1
(en)
|
2017-06-05 |
2018-12-13 |
Becton, Dickinson And Company |
Sample indexing for single cells
|
|
KR102399851B1
(en)
*
|
2017-08-25 |
2022-05-19 |
더 가버닝 카운슬 오브 더 유니버시티 오브 토론토 |
Compositions and methods for detecting and treating insulin resistance
|
|
PE20251292A1
(en)
|
2018-03-08 |
2025-05-14 |
Incyte Corp |
DIOLIC AMINOPYRAZINE COMPOUNDS AS PI3K-GAMMA INHIBITORS
|
|
WO2019197845A1
(en)
*
|
2018-04-12 |
2019-10-17 |
Mina Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
ES2945191T3
(en)
|
2018-05-03 |
2023-06-29 |
Becton Dickinson Co |
High-throughput multi-omics sample analysis
|
|
ES3014208T3
(en)
|
2018-05-03 |
2025-04-21 |
Becton Dickinson Co |
Molecular barcoding on opposite transcript ends
|
|
JPWO2019240164A1
(en)
*
|
2018-06-13 |
2021-06-24 |
第一三共株式会社 |
Myocardial damage drug
|
|
WO2020010003A1
(en)
|
2018-07-02 |
2020-01-09 |
Incyte Corporation |
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
|
|
AR115847A1
(en)
|
2018-07-25 |
2021-03-03 |
Ionis Pharmaceuticals Inc |
COMPOUNDS AND METHODS TO REDUCE THE EXPRESSION OF ATXN2
|
|
US12398402B2
(en)
|
2018-09-12 |
2025-08-26 |
Fred Hutchinson Cancer Center |
Reducing CD33 expression to selectively protect therapeutic cells
|
|
EP4471156A3
(en)
|
2018-10-01 |
2025-02-26 |
Becton, Dickinson and Company |
Determining 5' transcript sequences
|
|
JP7618548B2
(en)
|
2018-11-08 |
2025-01-21 |
ベクトン・ディキンソン・アンド・カンパニー |
Whole-transcriptome analysis of single cells using random priming
|
|
EP3894552A1
(en)
|
2018-12-13 |
2021-10-20 |
Becton, Dickinson and Company |
Selective extension in single cell whole transcriptome analysis
|
|
WO2020132558A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing pmp22 expression
|
|
US20220072024A1
(en)
*
|
2018-12-28 |
2022-03-10 |
Dicerna Pharmaceuticals, Inc. |
Compositions and methods for inhibiting hmgb1 expression
|
|
EP4242322B1
(en)
|
2019-01-23 |
2024-08-21 |
Becton, Dickinson and Company |
Oligonucleotides associated with antibodies
|
|
CN113454234B
(en)
|
2019-02-14 |
2025-03-18 |
贝克顿迪金森公司 |
Heterozygote targeted and whole transcriptome amplification
|
|
DK3938542T3
(en)
*
|
2019-03-13 |
2025-09-29 |
Goodgut S L |
IMPROVED METHOD FOR THE SCREENING, DIAGNOSIS AND/OR MONITORING OF COLORECTAL ADVANCED NEOPLASIA, ADVANCED ADENOMA AND/OR COLORECTAL CANCER
|
|
CN115806976A
(en)
*
|
2019-03-20 |
2023-03-17 |
中国科学院上海营养与健康研究所 |
Protein Translation Using Circular RNA and Its Applications
|
|
US20220333105A1
(en)
*
|
2019-06-03 |
2022-10-20 |
Quralis Corporation |
Oligonucleotides and methods of use for treating neurological diseases
|
|
EP4004231B1
(en)
|
2019-07-22 |
2025-11-12 |
Becton, Dickinson and Company |
Single cell chromatin immunoprecipitation sequencing assay
|
|
CN114729350A
(en)
|
2019-11-08 |
2022-07-08 |
贝克顿迪金森公司 |
Obtaining full-length V (D) J information for immunohistorian sequencing using random priming
|
|
EP4077666A1
(en)
|
2019-12-16 |
2022-10-26 |
Alnylam Pharmaceuticals, Inc. |
Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
|
|
CN115244184A
(en)
|
2020-01-13 |
2022-10-25 |
贝克顿迪金森公司 |
Methods and compositions for quantification of protein and RNA
|
|
US12188010B2
(en)
|
2020-01-29 |
2025-01-07 |
Becton, Dickinson And Company |
Barcoded wells for spatial mapping of single cells through sequencing
|
|
EP3868884A1
(en)
*
|
2020-02-19 |
2021-08-25 |
Aarhus Universitet |
Method for subtyping bladder cancer using aptamers
|
|
WO2021173719A1
(en)
|
2020-02-25 |
2021-09-02 |
Becton, Dickinson And Company |
Bi-specific probes to enable the use of single-cell samples as single color compensation control
|
|
EP4146807A4
(en)
*
|
2020-05-08 |
2024-09-04 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity
|
|
WO2021231779A1
(en)
*
|
2020-05-14 |
2021-11-18 |
Becton, Dickinson And Company |
Primers for immune repertoire profiling
|
|
WO2021247593A1
(en)
|
2020-06-02 |
2021-12-09 |
Becton, Dickinson And Company |
Oligonucleotides and beads for 5 prime gene expression assay
|
|
AR122534A1
(en)
|
2020-06-03 |
2022-09-21 |
Triplet Therapeutics Inc |
METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY
|
|
EP4165185A4
(en)
*
|
2020-06-11 |
2025-09-10 |
Genetic Intelligence Inc New York Ny |
COMPOSITIONS FOR FN GENE MODULATION AND METHODS THEREFOR
|
|
US11932901B2
(en)
|
2020-07-13 |
2024-03-19 |
Becton, Dickinson And Company |
Target enrichment using nucleic acid probes for scRNAseq
|
|
WO2022026909A1
(en)
|
2020-07-31 |
2022-02-03 |
Becton, Dickinson And Company |
Single cell assay for transposase-accessible chromatin
|
|
EP4247967A1
(en)
|
2020-11-20 |
2023-09-27 |
Becton, Dickinson and Company |
Profiling of highly expressed and lowly expressed proteins
|
|
CN116685850A
(en)
|
2020-12-15 |
2023-09-01 |
贝克顿迪金森公司 |
Single cell secretome analysis
|
|
IL282597B
(en)
*
|
2021-04-22 |
2022-08-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Birds for creating female offspring and methods for creating them
|
|
IL311872A
(en)
*
|
2021-10-15 |
2024-06-01 |
Codexis Inc |
Engineered terminal deoxynucleotidyl transferase variants
|
|
GB202117593D0
(en)
*
|
2021-12-06 |
2022-01-19 |
Royal Veterinary College |
Methods
|
|
KR20250024748A
(en)
*
|
2022-04-08 |
2025-02-19 |
세카나 파머씨티컬스 지엠비에이치 엔 씨오. 케이지 |
Oligonucleotides for decreasing the expression of leucine rich repeat kinase 2 (LRRK2) and their use for preventing and/or treating human diseases
|
|
JP2025519286A
(en)
|
2022-06-01 |
2025-06-25 |
イー-セラピューティクス・ピーエルシー |
Inhibitors of Expression and/or Function
|
|
CN115813944A
(en)
*
|
2022-07-01 |
2023-03-21 |
青岛市中心医院 |
Preparation with angiogenesis effect
|
|
WO2024023267A2
(en)
*
|
2022-07-27 |
2024-02-01 |
E-Therapeutics Plc |
Nucleic acid compounds
|
|
WO2024023252A2
(en)
*
|
2022-07-27 |
2024-02-01 |
E-Therapeutics Plc |
Nucleic acid compounds
|
|
EP4573198A2
(en)
*
|
2022-08-18 |
2025-06-25 |
Alnylam Pharmaceuticals, Inc. |
Universal non-targeting sirna compositions and methods of use thereof
|
|
AU2024218976A1
(en)
*
|
2023-02-06 |
2025-09-11 |
E-Therapeutics Plc |
Inhibitors of expression and/or function
|
|
WO2025007063A1
(en)
|
2023-06-30 |
2025-01-02 |
Avidity Biosciences, Inc. |
Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates
|
|
CN120082549B
(en)
*
|
2024-08-22 |
2025-11-07 |
中国科学院动物研究所 |
A method for inhibiting rice virus replication by targeting viral small RNAs
|